Furthermore, a series of core clock and output genes (BMAL1, ARNTL and PER1,2) have been identified with the anti-tumor effects which are subject to the regulation through a non-genetic route, e.g. epigenetic changes [46]. This evidence concerns the gene BMAL1 and neoplasm.